Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenergic alpha1 receptor (α1-AR) is a G protein-coupled receptor that mediates various physiological responses, most notably smooth muscle contraction and vasoconstriction. It is primarily activated by norepinephrine and epinephrine. There are three subtypes: α1A, α1B, and α1D, each with distinct tissue distributions and functions. Activation leads to stimulation of phospholipase C (PLC) via Gq/11 proteins, resulting in increased intracellular calcium and activation of protein kinase C. Alpha‐blockers targeting these receptors are used therapeutically for hypertension and benign prostatic hyperplasia.
Gq/11 → PLC → IP3/DAG → ↑Ca²⁺/PKC, leading to smooth muscle contraction and other cellular effects.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Alpha1 Receptor (α1-AR).